- Home
- REVG vs MDXG Comparison
REVG vs MDXG Comparison
Compare REVG & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVG
- MDXG
- Stock Information
- Founded
- REVG 2008
- MDXG 2006
- Country
- REVG United States
- MDXG United States
- Employees
- REVG N/A
- MDXG N/A
- Industry
- REVG Auto Manufacturing
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- REVG Consumer Discretionary
- MDXG Health Care
- Exchange
- REVG Nasdaq
- MDXG Nasdaq
- Market Cap
- REVG 1.3B
- MDXG 1.1B
- IPO Year
- REVG 2017
- MDXG N/A
- Fundamental
- Price
- REVG $33.56
- MDXG $9.48
- Analyst Decision
- REVG Hold
- MDXG Strong Buy
- Analyst Count
- REVG 4
- MDXG 5
- Target Price
- REVG $33.75
- MDXG $12.00
- AVG Volume (30 Days)
- REVG 638.6K
- MDXG 781.2K
- Earning Date
- REVG 12-11-2024
- MDXG 10-30-2024
- Dividend Yield
- REVG 0.73%
- MDXG N/A
- EPS Growth
- REVG 512.99
- MDXG N/A
- EPS
- REVG 4.72
- MDXG 0.52
- Revenue
- REVG $2,380,200,000.00
- MDXG $342,804,000.00
- Revenue This Year
- REVG $5.24
- MDXG $9.56
- Revenue Next Year
- REVG N/A
- MDXG $9.19
- P/E Ratio
- REVG $6.90
- MDXG $18.28
- Revenue Growth
- REVG N/A
- MDXG 10.93
- 52 Week Low
- REVG $16.00
- MDXG $5.47
- 52 Week High
- REVG $35.96
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- REVG 59.89
- MDXG 62.95
- Support Level
- REVG $32.53
- MDXG $9.07
- Resistance Level
- REVG $35.53
- MDXG $10.14
- Average True Range (ATR)
- REVG 1.35
- MDXG 0.31
- MACD
- REVG 0.18
- MDXG -0.11
- Stochastic Oscillator
- REVG 65.55
- MDXG 41.67
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. It provides customized vehicle solutions for applications including essential needs, industrial and commercial, and consumer leisure. The operating segments of the company are Fire & Emergency, Commercial, and Recreation. The products of the company are sold to municipalities, government agencies, private contractors, consumers, and industrial and commercial end-users. It derives a majority of the revenue from the Fire and Emergency segment which includes manufacturing of fire apparatus and ambulance products. The company operates in the United States, Canada, and the rest of the world.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.